Abstract
Protein kinase CK2 is a serine/threonine protein kinase involved in various aspects of cellular regulation. The regulatory β-subunit of CK2 exerts a central role not only in mediating formation of tetrameric CK2 complexes but also as a docking partner for several protein kinases. In this study, CK2β is found to interact with the human cell cycle checkpoint kinase Chk1. The Chk1-interacting region of CK2β is localized at the C-terminus and the complex between CK2β and Chk1 is devoid of the catalytic CK2α-subunit. The interaction between CK2β and Chk1 leads to an increase in the Cdc25C phosphorylation activity of Chk1. The screening of several cell lines has revealed that the association between CK2β and Chk1 also occurs in vivo at a different degree. Collectively, these studies confirm the implication of the regulatory β-subunit of protein kinase CK2 in cell cycle regulation and identify a novel mechanism for the activation of Chk1 protein kinase.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
al-Khodairy F, Fotou E, Sheldrick KS, Griffiths DJ, Lehmann AR and Carr AM . (1994). Mol. Biol. Cell, 5, 147–160.
Boldyreff B and Issinger O-G . (1997). FEBS Lett., 403, 197–199.
Boldyreff B, Meggio F, Pinna LA and Issinger O-G . (1993). Biochemistry, 32, 12672–12677.
Bren GD, Pennington KN and Paya CV . (2000). J. Mol. Biol., 297, 1245–1258.
Chen M, Li D, Krebs EG and Cooper JA . (1997). Mol. Cell. Biol., 17, 1904–1912.
Chen P, Luo C, Deng Y, Ryan K, Register J, Margosiak S, Tempczyk-Russell A, Nguyen B, Myers P, Lundgren K, Kan CC and O'Connor PM . (2000). Cell, 100, 681–692.
Diaz-Meco MT, Dominguez I, Sanz L, Dent P, Lozano J, Municio MM, Berra E, Hay RT, Sturgill TW and Moscat J . (1994). EMBO J., 13, 2842–2848.
Grahm KC and Litchfield DW . (2000). J. Biol. Chem., 275, 5003–5010.
Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM and Piwnica-Worms H . (2000). J. Biol. Chem., 275, 5600–5605.
Guerra B and Issinger O-G . (1999). Electrophoresis, 20, 391–408.
Guerra B, Siemer S, Boldyreff B and Issinger O-G . (1999). FEBS Lett., 462, 353–357.
Hagemann C, Kalmes A, Wixler V, Wixler L, Schuster T and Rapp UR . (1997). FEBS Lett., 403, 200–202.
Hathaway GM, Lubben TH and Traugh JA . (1980). J. Biol. Chem., 255, 8038–8041.
Li D, Dobrowolska G, Aicher LD, Chen M, Wright JH, Drueckes P, Dunphy EL, Munar ES and Krebs EG . (1999). J. Biol. Chem., 274, 32988–32996.
Liu Q, Guntuku S, Cui X-S, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA and Elledge SJ . (2000). Genes Dev., 14, 1448–1459.
Niefind K, Guerra B, Ermakowa I and Issinger O-G . (2001). EMBO J., 20, 5320–5331.
Niefind K, Guerra B, Pinna LA, Issinger O-G and Schomburg D . (1998). EMBO J., 17, 2451–2462.
Pelliccioli A, Lee SE, Lucca C, Foiani M and Haber JE . (2001). Mol. Cell, 7, 293–300.
Peng C-Y, Graves P, Thoma RS, Wu Z, Shaw AS and Piwnica-Worms H . (1997). Science, 277, 1501–1505.
Pinna LA . (1990). Biochim. Biophys. Acta, 1054, 267–284.
Pinna LA and Meggio F . (1997). Prog. Cell Cycle Res., 3, 77–97.
Sanchez J, Bachant J, Wang H, Hu F, Liu D, Tetzlaff M and Elledge SJ . (1999). Science, 286, 1166–1171.
Takai H, Tominaga K, Motoyama N, Minamishima YA, Nagahama H, Tsukiyama T, Ikeda K, Nakayama K and Nakanishi M . (2000). Genes Dev., 14, 1439–1447.
Toczyski DP, Galgoczy DJ and Hartwell LH . (1997). Cell, 90, 1097–1106.
Walworth N, Davey S and Beach D . (1993). Nature, 363, 368–371.
Zhang C, Vilk G, Canton DA and Litchfield D . (2002). Oncogene, 21, 3754–3764.
Zhao H and Piwnica-Worms H . (2001). Mol. Cell. Biol., 21, 4129–4139.
Zhou BB and Elledge SJ . (2000). Nature, 408, 433–439.
Acknowledgements
We thank Dr Richard Kolodner for use of SMART Chromatographic System, Dr Karsten Niefind for the release of modeling data and Drs Nelson Chau and Isabella Gazzoli for helpful discussions and suggestions. This work was supported by the Danish Cancer Society (Grant No. DP00035) to BAG and the National Cancer Institute (Grant No. CA43054) to JYJW.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guerra, B., Issinger, OG. & Wang, J. Modulation of human checkpoint kinase Chk1 by the regulatory β-subunit of protein kinase CK2. Oncogene 22, 4933–4942 (2003). https://doi.org/10.1038/sj.onc.1206721
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206721
Keywords
This article is cited by
-
Essential role of CK2α for the interaction and stability of replication fork factors during DNA synthesis and activation of the S-phase checkpoint
Cellular and Molecular Life Sciences (2022)
-
Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis
Molecular Diversity (2021)
-
Casein kinase 2 modulates the spindle assembly checkpoint to orchestrate porcine oocyte meiotic progression
Journal of Animal Science and Biotechnology (2020)
-
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors
Scientific Reports (2019)
-
Down-regulation of CK2α correlates with decreased expression levels of DNA replication minichromosome maintenance protein complex (MCM) genes
Scientific Reports (2019)